Searchable abstracts of presentations at key conferences in endocrinology

ea0029p381 | Clinical case reports - Pituitary/Adrenal | ICEECE2012

Spontaneous remission of acromegaly due to pituitary apoplexy: case report

Sucaliuc A. , Coles D. , Grigorascu L. , Caragheorgheopol A. , Hortopan D. , Grigorie D.

Introduction: Pituitary apoplexy is a rare acute complication in patients with functioning pituitary adenomas (including acromegaly) often followed by hypopituitarism and occasionally may show remission of symptoms after an apoplectic episode. We report this in an acromegalic patient who developed remission following pituitary apoplexy.Case report: A 24 years old woman is diagnosed with acromegaly after presenting for a period of 6 months moderate headac...

ea0011p42 | Bone | ECE2006

The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

Paun D , Grigorie D , Ghemigian A , Cofaru F , Dumitrache C

The nitrogen-containing bisphosphonate Risedronate have been shown to reduce the risk of both spine and nonspine fractures by reducing bone turnover, increasing bone mass and improving bone strength.Objective: To study the effects of once-weekly Risedronate on bone turnover markers in osteoporotic patients after three month of treatment.Patients and methods: Study group included 50 osteoporotic patients (3 males and 47 females), me...

ea0011p46 | Bone | ECE2006

The effect of once-weekly Risedronate on biochemical markers of bone turnover after three month of treatment

Paun D , Grigorie D , Ghemigian A , Cofaru F , Dumitrache C

The nitrogen-containing bisphosphonate Risedronate have been shown to reduce the risk of both spine and nonspine fractures by reducing bone turnover, increasing bone mass and improving bone strength.Objective: To study the effects of once-weekly Risedronate on bone turnover markers in osteoporotic patients after three month of treatment.Patients and methods: Study group included 50 osteoporotic patients (3 males and 47 females), me...

ea0026p605 | Clinical case reports | ECE2011

Primary hyperparathyroidism in pregnancy: a case report

Grigorie D , Sucaliuc A , Ranetti A , Ivan M

Introduction: It is supposed that primary hyperparathyroidism (pHPT) during pregnancy is associated with significant maternal and fetal risks as high as 67 and 80%, respectively. The very few case reports published referred mainly to unrecognized pHPT or diagnosed during pregnancy. We report the case of a woman with known asymptomatic pHPT who became pregnant.Case-report: A woman, 29 years, was diagnosed with pHPT a year before becoming pregnant; her bio...

ea0026p628 | Clinical case reports | ECE2011

Five year follow-up of recurrent parathyroid carcinoma in a young man: a case report

Grigorie D , Ivan M , Ionescu M , Ghemigian M , Stanescu B , Ioachim D , Sucaliuc A , Diaconescu A

Introduction: Parathyroid carcinoma is a rare cause of pHPT – <1%.Case report: We report the case of a 25-year-old man who presented with acute severe hypercalcemia (19 mg/dl) and extremely high serum PTH (2737 pg/ml). He was initially treated with i.v. fluids, calcitonin and pamidronate and total calcium decreased to 12.7 mg/dl. A left lower parathyroidectomy (tumour with microvascular invasion and intact capsule) was performed with a prompt de...

ea0011p24 | Bone | ECE2006

Effect of melatonin on gene expression and mineralization in mouse osteoblast culture

Manda D , Busu C , Ianas O , Stefanovici G , Calarasu R , Grigorie D , Dumitrache C

The physiological and neuroendocrine functions of the pineal gland hormone, melatonin and its therapeutic potential critically depend on the understanding of its target sites and its mechanism of action. There is evidence that melatonin promoted osteoblast differentiation and mineralization in MC3T3-E1 (mouse preosteoblast) and rat osteoblast-like osteosarcoma 17/2.8 cells. Our group set up an experimental model of mouse osteoblast culture. As a marker specific for osteoblast ...